Leishmaniasis is a neglected tropical disease that affects 12 million people worldwide. The
disease has high morbidity and mortality rates and is prevalent in over 80 countries, leaving …

Human parasitic infections cause a combined global mortality rate of over one million
people per annum and represent some of the most challenging diseases for medical …

In this serum panel–based study, we evaluated the accuracy of serological tests originally
developed for visceral leishmaniasis (VL), for diagnosis of mucosal leishmaniasis (ML). A …

Leishmaniasis is a neglected tropical disease that is caused by the Leishmania parasite. It is
estimated that there are more than 350 million people at risk of infection annually. Current …

Background: Natural products have been important resources for potential drug
development. Among the many classes of natural products, alkaloids have the most …

Abstract Background and Objective Cutaneous leishmaniasis (CL) is still considered to be
an uncontrolled endemic disease that spreads in many countries. The current study aimed to …

BACKGROUND፡ Cutaneous leishmaniasis is considered one of the major neglected
tropical diseases. Drug resistance, limitary efficacy, and severe side effects remain a …

Cutaneous Leishmaniasis is the only neglected disease that keeps progressing and
spreading in many environmental conditions. Approximately two million new cases in …

Leishmaniasis is a common disease between humans and animals. It is caused by different
protozoan species of the Leishmania genus and is transmitted by female Phlebotomus …

Mucosal leishmaniasis (ML) is a chronic and rare form of leishmaniasis that causes
malignant lesions in the mucosa of the nasal, pharyngeal, and laryngeal regions. We …